Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,280.00p
   
  • Change Today:
    -42.00p
  • 52 Week High: 1,380.00
  • 52 Week Low: 783.00
  • Currency: UK Pounds
  • Shares Issued: 82.59m
  • Volume: 208
  • Market Cap: £1,057.18m
  • RiskGrade: 125

Liberum hikes target price on Oxford Biomedica

By Iain Gilbert

Date: Tuesday 28 Apr 2020

LONDON (ShareCast) - (Sharecast News) - Analysts at Liberum hiked their target price on gene and cell therapy company Oxford BioMedica from £8.60 per share to £10.90 on Tuesday, citing demand at its new OxBox manufacturing facility.

Liberum said Oxford Biomedica had made "enormous progress" since its initiation of coverage in 2019, highlighting the completion of the new OxBox manufacturing facility for having already unlocked demand for future capacity.

The broker stated that with Oxford Biomedica now working in collaboration with the Jenner Institute consortium as a manufacturing partner for its potential Covid-19 vaccine, while it was "too early to estimate its potential", the move still represented a 12-month upside option.

Liberum also pointed out that late last year, Novartis extended its vector collaboration with the group, and in March, Juno Therapeutics chose OXB as its vector partner.

In addition to upping its price target on the group, Liberum also reiterated its 'buy' rating on OXB.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 1,280.00p
Change Today -42.00p
% Change -3.18 %
52 Week High 1,380.00
52 Week Low 783.00
Volume 208
Shares Issued 82.59m
Market Cap £1,057.18m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
77.75% below the market average77.75% below the market average77.75% below the market average77.75% below the market average77.75% below the market average
57.69% below the sector average57.69% below the sector average57.69% below the sector average57.69% below the sector average57.69% below the sector average
Price Trend
82.05% above the market average82.05% above the market average82.05% above the market average82.05% above the market average82.05% above the market average
73.77% above the sector average73.77% above the sector average73.77% above the sector average73.77% above the sector average73.77% above the sector average
Income Not Available
Growth
49.29% above the market average49.29% above the market average49.29% above the market average49.29% above the market average49.29% above the market average
31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average

What The Brokers Say

Strong Buy 5
Buy 0
Neutral 2
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 28-Jul-2021

Time Volume / Share Price
08:00 208 @ 1,280.00p

OXB Key Personnel

CEO John Dawson
CFO Stuart Paynter

Top of Page